Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text]

Autor: Joy, Bartholomew, Tanea, Washington, Sharon, Bergeron, Danelle, Nielson, Jennifer, Saggio, Lindsay, Quirk
Rok vydání: 2016
Zdroj: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. 34(1)
ISSN: 1532-8457
Popis: Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively.
Databáze: OpenAIRE